Full text is available at the source.
Mannose-Conjugated Cholesterol Containing Lipid Nanoparticles for Active Targeted mRNA Delivery to Liver Sinusoidal Endothelial and Kupffer Cells
Mannose-coated cholesterol lipid particles for targeted mRNA delivery to liver filtering and immune cells
AI simplified
Abstract
Mannosylated lipid nanoparticles enhanced uptake into liver sinusoidal endothelial cells and Kupffer cells over hepatocytes following intravenous administration in mice.
- Lipid nanoparticle delivery of mRNA is influenced by serum ApoE binding, limiting effectiveness in nonhepatocyte liver diseases.
- Incorporating mannose-conjugated cholesterol into lipid nanoparticles may improve targeting to specific liver cell types.
- Mannosylated lipid nanoparticles showed significantly greater uptake in liver sinusoidal endothelial cells and Kupffer cells compared to hepatocytes.
- Uptake correlated with the expression of mannose receptors (CD206) in LSECs and Kupffer cells.
- Reducing the acyl chain length in PEG lipids could enhance the activity and selectivity of lipid nanoparticles by increasing accessible mannose on their surface.
AI simplified